Learn more about Euretos computational disease model and how it predicts many of the known drug targets for RA.
List view / Grid view
Understanding the mechanisms in lung formation could develop new therapeutic approaches for respiratory conditions.
Researchers have completely decoded the human Y chromosome, which may result in more effective treatment for digestive disorders.
This ebook outlines Euretos’ approach to target discovery and indication expansion.
Bridging the gap: using organ-on-a-chip as an experimental tool to develop (cost) effective therapeutics
25 July 2023 | By CN Bio
The webinar will explore primary concerns in drug discovery development and why drugs fail.
Swedish study reveals a significant link between specific gut bacteria and the development of coronary atherosclerotic plaques, a leading cause of heart attacks.
Swiss researchers have achieved near-perfect control over the manipulation of individual DNA molecules, allowing them to be identified and characterised with unprecedented precision
US researchers use genome sequencing to reveal genetic basis for disabling pansclerotic morphea, a severe inflammatory disease.
Single-cell transcriptomic RNA sequencing analysis has allowed US researchers to identify the specific populations and the dynamic transition states during senescence initiation and progression.
Spanish scientists have developed a new method to identify between cancerous and healthy cells for cases of acute myeloid leukaemia (AML).
University of Oxford finds rapid metagenomics can produce accurate results 18-42 hours quicker than conventional tests for antimicrobial resistance in bloodstream infections, which could save lives and reduce the misuse of antibiotics.
Comparison of single cell dispensing efficiency between Namocell Single Cell Dispenser and limiting dilution method.